Janssen responds to NICE draft guidance not to recommend SPRAVATO® (esketamine) nasal spray for treatment-resistant major depressive disorder (1) - PharmiWeb.com

Submitted by Anonymous (not verified) on Thu, 09/03/2020 - 15:25

Janssen responds to NICE draft guidance not to recommend SPRAVATO® (esketamine) nasal spray for treatment-resistant major depressive disorder (1)  PharmiWeb.com